Product Images Oxcarbazepine

Oxcarbazepine is a prescription drug (RX ONLY) supplied in a HD2 quantity with NDC# 70518-2370-01. The manufacturer is Breckenridge located in Boca Raton, FL, and the repackager is RemedyRepack Inc. from Indiana, PA. It is important to keep this medication out of reach of children. It is advised to read the package insert before use and store the medication at a temperature between 20-26°C (63-77°F), with excursion permitted to 15-30°C (59-86°F) [See USP]. The expiration date and LOT# are not readable.*

Oxcarbazepine is a prescription medication that comes in a package of 100 HD2 tablets. The National Drug Code (NDC) number for this medication is 70518-2370-00 and it is manufactured by Breckenridge in Boca Raton, Florida. The lot number and expiration date are not provided. The medication should be kept out of reach of children and stored between 20-26°C (63-77°F) with permitted excursions to 15-30°C (59-86°F). The package insert should be consulted for directions on how to use the medication. This particular package has been repackaged by RemedyRepack Inc. in Indiana, PA.*

The text displays statistical analysis related to the exit rate and log-rank test in a trial, with a graph indicating results over time. The trial includes a placebo.*

The text describes the seizure rate and the statistical analysis performed using the log-rank test. The p-value obtained from the test is 0.046, which indicates a significant difference between the groups being compared. The graph shows the number of days from the first dose to the first seizure, and the treatment groups being compared are Oxcarbazepine and placebo.*

This is a survival analysis report with the test result of log-rank test showing a significant p-value of 0.0001. A chart is also displayed showing the time it takes to exit in days for a treatment group categorized as either "HIGH" or "LOW".*

This is a survival analysis of two treatment groups (high and low) evaluating their exit rate over time. The log-rank test resulted in a p-value of 0.0001 indicating a statistically significant difference in exit rate between the two groups. The time to exit is measured in days over a period of 130 days. The data presented in the text is primarily a graph with the x-axis representing time to exit (in days) and the y-axis representing the percentage of participants exiting the study. The treatment group with a high exit rate is marked on the graph.*